Due to a production error, there were inaccuracies in the section numbering. The corrected subsection numbering should read as follows:
1. Introduction
2. Immunotheraputic Strategies Targeting the TME
2.1 Therapeutic Strategies Based on TME Inhibitory Signaling
2.1.1 Targeting TME Physical Barriers
2.1.2 Targeting Immune Checkpoints
2.1.3 Targeting Immunosuppresive Cells
2.1.4 Targeting Inhibitory Cytokines
2.1.5 Targeting Metabolic Inhibition Signaling
2.2 Therapeutic Strategies Based on TME Stimulatory Signals
2.2.1 Targeting Stimulatory Checkpoints
2.2.2 Application of Stimulating Cytokines
2.2.3 Enhancing Antigen Presentation
2.2.4 Application of Immune Effector cells
3. Challenges Faced by Time Research and Solutions
3.1 Complexity of TIME
3.2 Spatiotemporal Heterogenity of TIME
3.3 Systemic Immunity Affects TME Immune Response
4. Summary and Prospect
The publisher apologizes for this mistake.
The original version of this article has been updated.
Summary
Keywords
cancer, tumor microenvironment, immunotherapy, inhibitory signaling, stimulatory signaling
Citation
Frontiers Production Office (2022) Erratum: Development of immunotherapy strategies targeting tumor microenvironment is fiercely ongoing. Front. Immunol. 13:1004587. doi: 10.3389/fimmu.2022.1004587
Received
27 July 2022
Accepted
27 July 2022
Published
11 August 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.